Conduct and analysis of bioavailability and bioequivalence studies. Part B Oral modified release formulations.

Conduct and analysis of bioavailability and bioequivalence studies. Part B, Oral modified release formulations.

Notes on use

Note (General)：: Issued also in French under title: Conduite et analyse des études de disponibilité et de bioéquivalence. Partie B. Formes pharmaceutiques à libér...

Search by Bookstore

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Material Type: 図書
ISBN: 0662252357
9780662252351
Title: Conduct and analysis of bioavailability and bioequivalence studies.
Volume: Part B
Part Title: Oral modified release formulations.
Author Heading: Canada. Health Canada.
Publication, Distribution, etc.: Ottawa, Ontario : Therapeutic Products Programme, Health Canada (出版)
Publication Date: [1996]
Publication Date (W3CDTF): 1996
Extent: iv, 134 pages
Size: 28 cm
Place of Publication (Country Code): CA
Text Language Code: eng
Content Type: text
Media Type: unmediated
Carrier Type: volume
Subject Heading: Drugs--Bioavailability.
Bioavailability--Research--Methodology.
Drugs--Therapeutic equivalency--Testing.
LCC: QV38
DDC: 615
NDLC: Y629
Target Audience: 一般
Note (General): Issued also in French under title: Conduite et analyse des études de disponibilité et de bioéquivalence. Partie B. Formes pharmaceutiques à libération modifiée.
Distributed by the Government of Canada Depository Services Program.
Holding library: 国立国会図書館
Call No.: Y629-97-102
Data Provider (Database): 国立国会図書館 : 国立国会図書館蔵書
https://ndlsearch.ndl.go.jp
Bibliographic ID (NDL): 028963340
http://id.ndl.go.jp/bib/028963340
OCLC No.: 37491751
https://www.worldcat.org/oclc/37491751
Cataloging Rule: RDA
Bibliographic Record Category (NDL): 211